Details of Disease

Disease Name

Cutaneous anthrax

skin anthrax; anthrax, skin type

Definition

An anthrax disease that results in infection located in skin, has material basis in Bacillus anthracis, which is transmitted by contact with infected animals or animal products. The infection has symptom skin lesion that eventually forms an ulcer with a black center.

Disease Hierarchy

DISFPT78: Anthrax

DISSRI0D: Skin disease caused by bacterial infection

DISA6ECE: Cutaneous anthrax

Disease Identifiers

MONDO ID

MONDO_0004215

MESH ID

C531621

UMLS CUI

C0003177

MedGen ID

1959

SNOMED CT ID

84980006

General Information of Disease (ID: DISA6ECE)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Doxycycline	DM7ICNU	Approved	Small molecular drug	[1]
Fusidic Acid	DMWVCF3	Approved	Small molecular drug	[2]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Benzylpenicillin	DMS9503	Phase 3	Small molecular drug	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 1 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
MARCHF6	OTBTA03N	Strong	Biomarker	[4]
------------------------------------------------------------------------------------

References

1	Doxycycline FDA Label
2	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
3	Cutaneous Anthrax. J Emerg Med. 2017 Feb;52(2):240-241.
4	Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.MMWR Morb Mortal Wkly Rep. 2002 Apr 5;51(13):279-81.